Associate Professor Menggang Yu Approved for over $1M Research Funding Award by the Patient-Centered Outcomes Research Institute

"The left panel represents a convex approximation for the 0-1 loss. In particular, the approximation is a surrogate logistic loss where the parameter "a" controls the shape of the surrogate. The right panel represents a non-convex approximation for the 0-1 loss where the parameter "a" controls the proximity of the surrogate."

Congratulations are in order to Associate Professor Menggang Yu for his imminent funding award from the Patient-Centered Outcomes Research Institute (PCORI) for his project entitled "Matching Complex Patients to Treatments: Innovative Statistical Scoring Methods for Treatment Selection". The project, which will run for 3 years, aims to develop and disseminate innovative statistical methods to rank possible treatments for patients according to their likelihood of achieving desirable patient outcomes. The ranking will be based on patient characteristics such as demographics and socio-economic variables, inpatient/outpatient diagnoses, comorbidity, pharmacy claims, health system and clinic information.

The award is one of four or five PCORI awards received recently by investigators at the University of Wisconsin School of Medicine and Public Health, and highlights the Department’s commitment to health services research.

The study is one of 46 proposals that PCORI approved for funding on Tuesday, April 21, to advance the field of comparative clinical effectiveness research (CER) and provide patients, healthcare providers, and other clinical decision makers with information that will help them make better-informed choices.
The award has been approved pending completion of a business and programmatic review by PCORI staff and issuance of a formal award contract to the University.

“This project was selected for PCORI funding not only for its scientific merit and commitment to engaging patients and other stakeholders, but also for its potential to fill an important gap in our health knowledge and give people information to help them weigh the effectiveness of their care options,” said PCORI Executive Director Joe Selby, MD, MPH. “We look forward to following the study’s progress and working with the University of Wisconsin School of Medicine and Public Health to share the results.”

Professor Yu’s study and the other projects approved for PCORI funding were selected through a highly competitive review process in which patients, clinicians, and other stakeholders joined clinical scientists to evaluate the proposals. Applications were assessed for scientific merit, how well they will engage patients and other stakeholders, and their methodological rigor among other criteria.

PCORI is an independent, non-profit organization authorized by Congress in 2010 to fund comparative clinical effectiveness research that will provide patients, their caregivers, and clinicians with the evidence-based information needed to make better-informed health and healthcare decisions. PCORI is committed to seeking input from a broad range of stakeholders to guide its work.

PCORI has approved $854 million to support 399 research studies and initiatives since it began funding research in 2012. For more information about PCORI funding, visit http://pcori.org.